Publications by authors named "Igor Briazgounov"
Background: The aim of this study was to determine the dose-response relationship for losartan, 2.5 to 100 mg, and to assess the safety and tolerability of losartan in hypertensive children 6 to 16 years of age.
Methods: This was a multicenter, randomized, double-blind, dose-response study.